NANBIOSIS Unit 20 promotes nanomedicine through an interactive educational game presented at several science outreach events in Barcelona.
Barcelona, October 2026 — NANBIOSIS is supporting science communication and public engagement through an educational game developed by its Unit 20 (FVPR), designed to introduce audiences to the fascinating world of nanomedicine and nanoparticle-based technologies.
Entitled “Missió nanoagent: El viatge d’una nanopartícula” (Nano-Agent Mission: The Journey of a Nanoparticle), this boardgame invites participants to explore the journey of a nanoparticle, helping them discover scientific concepts related to nanotechnology and its biomedical applications. The initiative also features the NANBIOSIS logo, raising awareness of the infrastructure and its research capabilities among the general public.
The game has been presented at several science outreach activities in Barcelona, including the Festa de la Ciència at the Centre de Cultura Contemporània de Barcelona (CCB) in April, and the European Researchers’ Night at CosmoCaixa, where it was featured in a session on Friday, 28 September. It was also showcased on 3 October at the Vall d’Hebron Research Institute (VHIR), as part of the 48h Open House Barcelona programme.
NANBIOSIS was also highlighted during the European Researchers’ Night through the talk “¡Hasta el cerebro! La increíble ruta de las nanopartículas” (All the Way to the Brain! The Incredible Journey of Nanoparticles), delivered by Fernanda Andrade at CosmoCaixa. The presentation featured the NANBIOSIS logo and discussed in vivo research results obtained through a service provided by the infrastructure.
Through initiatives like these, NANBIOSIS Units contribute not only to biomedical research and technological development but also to bringing science closer to society, making complex topics such as nanomedicine more accessible and engaging for different audiences.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
